Papers

New Publications

  1. Marinela Capanu, Irene Orlow, Marianne Berwick, Amanda J. Hummer, Duncan C. Thomas and Colin B. Begg.
    The use of hierarchical models for estimating relative risks of individual genetic variants: An application to a study of melanoma
    Statist. Med. 2008; 27:1973-1992

Previous Publications

  1. Stitzenberg KB, Thomas NE, Dalton K, Brier SE, Ollila DW, Berwick M, Mattingly D, Millikan RC.
    Distance to diagnosing provider as a measure of access for patients with melanoma.
    Arch Dermatol. 2007 Aug;143(8):991-8.
  2. Thomas NE, Edmiston SN, Alexander A, Millikan RC, Groben PA, Hao H, Tolbert D, Berwick M, Busam K, Begg CB, Mattingly D, Ollila DW, Tse CK, Hummer A, Lee-Taylor J, Conway K.
    Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma.
    Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):991-7.
  3. Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M; GEM Study Group.
    CDKN2A germline mutations in individuals with cutaneous malignant melanoma.
    J Invest Dermatol. 2007 May;127(5):1234-43. Epub 2007 Jan 11.
  4. Kricker A, Armstrong BK, Goumas C, Litchfield M, Begg CB, Hummer AJ, Marrett LD, Theis B, Millikan RC, Thomas N, Culver HA, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Zanetti R, Berwick M; for the GEM Study Group.
    Ambient UV, personal sun exposure and risk of multiple primary melanomas.
    Cancer Causes Control. 2007 Apr;18(3):295-304. Epub 2007 Jan 6.
  5. Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Busam K, From L, Mujumdar U, Wilcox H, Begg CB, Berwick M.
    Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma.
    Cancer Res. 2006 Sep 15;66(18):9330-7.
  6. Berwick M, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Wilcox H, Begg CB; GEM Study Group.
    The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
    Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1520-5.
  7. Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Berwick M; GEM Study Group.
    A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma.
    Int J Epidemiol. 2006 Jun;35(3):756-64. Epub 2006 Mar 23.
  8. Millikan RC, Hummer A, Begg C, Player J, de Cotret AR, Winkel S, Mohrenweiser H, Thomas N, Armstrong B, Kricker A, Marrett LD, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Mujumdar U, Berwick M.
    Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study.
    Carcinogenesis. 2006 Mar;27(3):610-8. Epub 2005 Oct 29.
  9. Hay J, Ostroff J, Martin A, Serle N, Soma S, Mujumdar U, Berwick M.
    Skin cancer risk discussions in melanoma-affected families.
    J Cancer Educ. 2005 Winter;20(4):240-6.
  10. Begg CB, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Mitra N, Busam K, From L, Berwick M; Genes Environment and Melanoma Study Group.
    Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
    J Natl Cancer Inst. 2005 Oct 19;97(20):1507-15.
  11. Purdue MP, From L, Armstrong BK, Kricker A, Gallagher RP, McLaughlin JR, Klar NS, Marrett LD for the Genes, Environment and Melanoma Study Group.
    Etiology and other factors predicting nevus-associated cutaneous malignant melanoma.
    Cancer Epidemiolog Biomarkers and Prevention 2005;14:2015-2022.
  12. Purdue MP, From L, Kahn HJ, Armstrong BK, Kricker A, Gallagher RP, McLaughlin JR, Klar NS, Marrett LD for the Genes, Environment and Melanoma Study Group.
    Etiologic factors associated with p53 immunostaining in cutaneous malignant melanoma.
    Int J Cancer 2005;117:486-93.
  13. Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Klotz JB, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Berwick M; GEM Study Group.
    Familial aggregation of melanoma risks in a large population-based sample of melanoma cases.
    Cancer Causes Control. 2004 Nov;15(9):957-65.

* PILOT STUDY: Berwick M, Orlow I, Mahabir S, Myskowski P, Coit D, Brady MS, Roy P, Song Y, Canchola R, Barz A, Halpern A, Bolognia J, Eng S, Elahi A, Begg CB.
Estimating the relative risk of developing melanoma in INK4A carriers.
Eur J Cancer Prev. 2004 Feb;13(1):65-70.

** THEORETICAL FRAMEWORK for GEM: Begg CB, Berwick M.
A note on the estimation of relative risks of rare genetic susceptibility markers.
Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):99-103.